Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells

The mevalonate pathway has emerged as a promising target for several solid tumors. Statins are inhibitors of the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the rate-limiting enzyme of this pathway, and are commonly used to treat patients with hypercholesterolemia. Pleiotropic antitumor mechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Göbel, Andy, Breining, Dorit, Rauner, Martina, Hofbauer, Lorenz C., Rachner, Tilman D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349912/
https://www.ncbi.nlm.nih.gov/pubmed/30692522
http://dx.doi.org/10.1038/s41419-019-1322-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349912/
https://www.ncbi.nlm.nih.gov/pubmed/30692522
http://dx.doi.org/10.1038/s41419-019-1322-x

Ejemplares similares